Cell expansion process plays a key role in therapeutic development, drug screening and core research. It is used for improving the outcome of transplantation and diseases such as rheumatoid arthritis and diabetes. New technology such as 3D cell expansion technology is accelerating the growth of this market.

1. IQ4I Research & Consultancy Pvt. Ltd. Page 1
Cell Expansion Global Market
–Forecast to 2022
Cell Expansion Global Market estimated to be worth $23.9 billion by 2022
IQ4I Research & Consultancy published a new report on “Cell Expansion Global
Market – Forecast To 2022” This report analyzes and studies the overall market, major
drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and
Rest of the World
IQ4I’s Report Contains 128 market data tables and 42 figures spread through 368
pages and an exhaustive TOC on “Cell Expansion Global Market [Products
(Instruments and Consumables), Cell Type (Animal Cell, Human Cell, Bacterial Cell,
Others) Applications (Regenerative Medicine and Stem Cell Research, Cancer Studies
and Others), End-Users (Academics and Research Institutes, Biotech and
Biopharmaceutical Company, Hospitals and Bio banks and Others), Region (North
America, Europe, APAC and RoW)]
This report analyzes the cell expansion global market in terms of market revenue ($ million)
for all segments and it enables cell expansion stakeholders such as cell expansion
instrument manufacturers, distributors and wholesalers, OEM/contract manufacturers,
clinics, hospitals, academics & various research institutes to identify and analyze market
expansion opportunities, upcoming technologies and competition in cell expansion global
market.
Cell expansion is defined as the production of daughter cells which basically arise from the
single cell. Cell expansion process plays a key role in therapeutic development, drug
screening and core research. At present, cell expansion is highly used for the expansion of
stem cells in improving outcomes in transplantation and in various diseases such as
rheumatoid arthritis and diabetes. Cell Expansion market is rapidly advancing at a strong
growth rate, as estimated by IQ4I Research, the cell expansion global market is expected to
grow at a double digit CAGR to reach $23,997 million by 2022.
Rising prevalence of chronic diseases, increasing government funding for research,
increased investments in cell based products, growing number of GMP-certified production
are some of the factors aiding in the growth of the market. 3D cell expansion technology and
high-growth in the countries of APAC region are some of the opportunities that are propelling
the growth of the market. However, high cost of cell-based products, use of unregulated
products, quality issues for end users, ethical concerns regarding research on cell biology
and stringent regulations are the factors that are hampering the market.
The cell expansion global market by product is segmented based on products, cell types,
applications and end-users. The market by product is segmented into instruments and

2. IQ4I Research & Consultancy Pvt. Ltd. Page 2
Cell Expansion Global Market
–Forecast to 2022
consumables, based on cell types the market is segmented into animal cell, human cell,
bacterial cell and others, based on applications it is segmented into regenerative medicines
and stem cell research, cancer studies and others. The instruments are segmented into cell
expansion supporting instruments, bioreactors and automatic cell expansion systems. Cell
expansion supporting equipments include flow cytometer, centrifuge, cell counters and
others. Bioreactors are segmented into stirred type bioreactors, microcarrier-based
anchorage-dependent stirred type bioreactors, suspension-based anchorage independent
stirred type bioreactors, hollow fibre/perfusion bioreactors, bubble column and airlift
bioreactor, single/disposable use bioreactor and others. Consumables are segmented into
reagents, media, sera and disposables. Disposables are further sub-segmented into culture
vessels, bioreactor accessories and others. Among bioreactors, single use bioreactors are
expected to drive the market high with a high double digit CAGR during 2015-2022. For
instance, ABEC, a U.S. based bioprocess solution company, launched a ‘Custom Single
Run’ (CSR) system in November 2015, with a total volume of 4,300L and a working volume
of 3,500L, making it the largest single use bioreactor available in the market.
By cell types, the cell expansion markets are divided into animal cells, human cells, bacterial
cells and others. The human cell includes adult stem cells, induced pluripotent stem cells
and embryonic stem cells. Adult stem cells are segmented into mesenchymal stem cells,
hematopoietic stem cells and neural stem cells. Mesenchymal stem cells are expected to
grow a high double digit CAGR due to increasing acceptance of stem cell therapies.
By application, the cell expansion markets are divided into regenerative medicine and stem
cell research, cancer studies and others. Regenerative medicine is expected to grow at a
high double digit CAGR from 2015-2022 by addressing many addressing many unmet
therapeutic needs. The end users of the cell expansion market are segmented into
academics and research institutes, biotechnology and biopharmaceutical companies,
hospital and bio-banks and others. Hospitals and biobanks are expected to grow at a high
double digit CAGR from 2015-2022.
The cell expansion global market by geography is divided into North America, Europe, Asia-
Pacific and Rest of the World (RoW). North America commanded the largest market share in
2015 due to increase in governmental funding and investments and better accessibility to
healthcare facilities has led the market growth in this region. However, Asia- Pacific region is
expected to have highest growth rate from 2015-2022 due to rising prevalence of lifestyle
diseases and government initiatives in establishing innovative technologies.

3. IQ4I Research & Consultancy Pvt. Ltd. Page 3
Cell Expansion Global Market
–Forecast to 2022
The major players in the cell expansion global market are Becton Dickenson and Company
(U.S.), Corning Inc (U.S.), Danaher Corporation (U.S.), Eppendorf AG (Germany), GE
Healthcare (U.K.), Lonza Group (Switzerland), Merck KGaA (Germany), Miltenyi Biotec
(Germany), Stemcell Technologies (Canada), Terumo Corporation (Japan) and
ThermoFisher Scientific Inc. (U.S.).
Reasons for buying this report:
 Analysis of the cell expansion global market by identifying various segments by
products, type, application, end-users and geography.
 Revenue forecast of the cell expansion global market and strategic analysis of each
submarket with respect to segmental growth trends.
 Analysis of the major market trends and factors driving or inhibiting the growth of the
cell expansion global market.
 Revenue forecast of the cell expansion global market with respect to North America,
Europe, Asia-Pacific and the Rest of the World (RoW) regions.
 Analysis of the opportunities for stakeholders by identifying the high-growth
segments of the market.
 Market share analysis of key players in cell expansion global market, details of their
product offerings, revenues, business strategies and SWOTs
 Patent trends, supply chain analysis of the cell expansion global market
 Single-use bioreactors market share analysis by major players 2015 (%)
 Established and Emerging players (66 companies) and their product offerings.

4. IQ4I Research & Consultancy Pvt. Ltd. Page 4
Cell Expansion Global Market
–Forecast to 2022
FIGURE 1
CELL EXPANSION GLOBAL MARKET SEGMENTATION
Cell Expansion Global Market
Instruments
Centrifuge
ByProducts
AnimalCell
By CellTypes
Consumables Regenerative
Medicine
Human Cell
By Applications
AdultStem Cell
Mesenchymal
Disposables
Reagents,
Media & Sera
Flow Cytometer
Supporting
Equipment
Others
Culture vessels
Embryonic
stem cell
Induced
Pluripotent
CancerStudies
Hollow Fiber
Bubble column/
Airlift
Bioreactor
Accessories
Suspension
Based
Microcarrier-
Based
Single use
Others
Stirred Type
Bioreactor
CellCounter
Others
Hematopoietic
Neural
By End Users
Others
Research
Institutes
Biopharma,
Biotech
Hospitals and
Bio Banks
Others
BacterialCell